Research & Development

Medical research has come a long way in the last hundred years, yet there are still many diseases for which there are no effective treatments.

That's why GlaxoSmithKline is committed to discovering and developing new medicines and vaccines.

Being a large company, we can truly make a difference because we can devote vast resources to discover and develop new medicines and vaccines to improve the health of New Zealanders and people worldwide. GSK has more than 20 research and development (R&D) facilities around the world, with an annual R&D budget of around $7 billion and more than 16,000 people employed in R&D.

Our Process

Once a compound has been identified as a potential drug candidate, it goes through an exacting, rigorous process to prove that the new drug is both safe and effective. There are a number of steps involved in researching and developing a new medicine.


Vaccine being administered to a patient
New Zealand

Our products

It takes between 12-15 years and costs over £500 million to discover and develop one medicine
 

Clinical Trials

GlaxoSmithKline is one of the world’s leaders in drug development and like all innovative pharmaceutical companies, we carry out a series of clinical trials to test each investigational drug for the potential to become a new medicine.

Medicines in Development

To view details of our portfolio of products currently in development, please click the link below to proceed to our International website which details our Product Pipeline.